182 related articles for article (PubMed ID: 16368902)
1. Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways.
Birrell MA; Wong S; McCluskie K; Catley MC; Hardaker EL; Haj-Yahia S; Belvisi MG
J Pharmacol Exp Ther; 2006 Mar; 316(3):1318-27. PubMed ID: 16368902
[TBL] [Abstract][Full Text] [Related]
2. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
[TBL] [Abstract][Full Text] [Related]
3. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.
Shoji T; Yoshida S; Mitsunari M; Miyake N; Tsukihara S; Iwabe T; Harada T; Terakawa N
J Reprod Immunol; 2007 Oct; 75(2):82-90. PubMed ID: 17617469
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models.
Jackson JR; Bolognese B; Hillegass L; Kassis S; Adams J; Griswold DE; Winkler JD
J Pharmacol Exp Ther; 1998 Feb; 284(2):687-92. PubMed ID: 9454815
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
9. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase.
King EM; Kaur M; Gong W; Rider CF; Holden NS; Newton R
J Pharmacol Exp Ther; 2009 Aug; 330(2):575-85. PubMed ID: 19435930
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
Lahti A; Sareila O; Kankaanranta H; Moilanen E
BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
[TBL] [Abstract][Full Text] [Related]
13. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
[TBL] [Abstract][Full Text] [Related]
14. Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages.
Szelenyi J; Selmeczy Z; Brozik A; Medgyesi D; Magocsi M
Neurochem Int; 2006 Jul; 49(1):94-103. PubMed ID: 16515823
[TBL] [Abstract][Full Text] [Related]
15. 2-Acylaminopyridin-4-ylimidazoles as p38 MAP kinase inhibitors: Design, synthesis, and biological and metabolic evaluations.
Ziegler K; Hauser DR; Unger A; Albrecht W; Laufer SA
ChemMedChem; 2009 Nov; 4(11):1939-48. PubMed ID: 19731280
[TBL] [Abstract][Full Text] [Related]
16. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.
Chialda L; Zhang M; Brune K; Pahl A
Respir Res; 2005 Apr; 6(1):36. PubMed ID: 15833106
[TBL] [Abstract][Full Text] [Related]
18. Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages.
Smolinska MJ; Horwood NJ; Page TH; Smallie T; Foxwell BM
Mol Immunol; 2008 Feb; 45(4):990-1000. PubMed ID: 17875324
[TBL] [Abstract][Full Text] [Related]
19. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways.
Choi HJ; Eun JS; Park YR; Kim DK; Li R; Moon WS; Park JM; Kim HS; Cho NP; Cho SD; Soh Y
Eur J Pharmacol; 2008 Dec; 601(1-3):171-8. PubMed ID: 18929556
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide.
Triggiani M; Granata F; Petraroli A; Loffredo S; Frattini A; Staiano RI; Monaco G; Marone G
Int Arch Allergy Immunol; 2009; 150(2):144-55. PubMed ID: 19439980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]